SHELTON, CONNECTICUT / ACCESS Newswire / January 13, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
The researchers took a “safety-first” approach. They deliberately excluded all viruses that infect humans or animals from the ...
Scientists have made the first step towards creating new species in the lab. Researchers have used artificial intelligence to ...
Food made from pigs engineered to be resistant to a porcine virus are as safe and nutritious to eat as pork currently on the ...
Mirum Pharmaceuticals acquires Bluejay Therapeutics, focusing on brelovitug for chronic hepatitis delta virus (HDV), a severe ...
Pharmaceutical Technology on MSN
Sanofi touts strong new launch sales amid looming Dupixent patent expiry
The company’s sales grew 9.9% YoY – driven by a diverse range of portfolio classics and new launches.
Arexvy, GSK's RSV vaccine, is now approved for all adults 18+ in the EU, addressing a significant public health concern. RSV ...
Artistic initiatives turn cybersecurity into immersive exhibits at the Museum of Malware Art, transforming cyber threats into thought-provoking experiences ...
Bats are critical viral reservoirs that harbor viromes with a high risk of cross-species transmission. However, the diversity ...
Zero trust offers organizations a way to help bolster security, but challenges remain when it comes to adoption and setting ...
Research about LENN -- a patent-pending, virus-mimicking platform technology that targets bladder cancer cells with mRNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results